Yaping Zhang on Platelet Adhesion Receptors
Yaping Zhang, Postdoc Associate at University of Illinois Chicago, shared on LinkedIn:
”Glad to participate in publishing the chapter “Platelet Adhesion Receptors” in the book Platelet Physiology I.
Andrew Mack, Yaping Zhang & Xiaoping Du
Platelet adhesion receptors are essential for platelet attachment, aggregation, and activation, which are critical for normal hemostasis and pathological thrombosis.
These receptors regulate where and how platelets adhere, influencing thrombus size and stability, and they trigger signaling pathways that coordinate with other adhesion and activation receptors to promote platelet spreading, secretion, clot retraction, and thrombus formation.
Platelets use several major receptor families—including integrins, LRR receptors such as GPIb-IX-V, immunoglobulin superfamily receptors like GPVI, and C-type lectins—to bind ligands such as collagen, von Willebrand factor, fibrinogen, and laminin, enabling interactions with vessel walls, other platelets, leukocytes, microbes, and tumor cells.
Because adhesion is central not only to hemostasis and thrombosis but also to inflammation and immune responses, targeting these receptors and their signaling pathways remains a key strategy for developing antithrombotic therapies.”
Read the chapter here.
Article: Platelet Adhesion Receptors
Authors: Andrew Mack, Yaping Zhang, Xiaoping Du
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 24, 2025, 11:46Rocío Vacik Díaz on Impact of LVAD Implantation at ECTH 2025
-
Oct 23, 2025, 06:03Melanie Daniel: Wonderful Presentation on Emicizumab by Mickael Rosa at ECTH
-
Oct 22, 2025, 06:17We Will Continue to Raise Awareness and Remind Rveryone That Donating Blood Means Saving Lives - Yeolyan Hematology and Oncology Center
-
Oct 21, 2025, 06:59Samwel Mikaye: Polycythemia and the Risk of Blood Clots
-
Oct 21, 2025, 06:58Samuel Nweke: Interpreting D-Dimer Results
-
Oct 24, 2025, 12:08Julián Alejandro Rivillas Compares Tenecteplase to Low-dose Alteplase: TRACE-5 Interim Phase II Results
-
Oct 24, 2025, 12:03Melissa Glasner on Integration of Gene Therapy Into Hemophilia Care
-
Oct 24, 2025, 11:41Yaping Zhang on Platelet Adhesion Receptors
-
Oct 24, 2025, 11:37Omid Jafari and Colleagues Present the VTE-BERT Natural Language Processing Model
-
Oct 24, 2025, 11:34Insights on IV Thrombolysis and Mechanical Thrombectomy from Benjamin Maier and Colleagues
-
Oct 23, 2025, 07:11Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
-
Oct 23, 2025, 07:05Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 21, 2025, 06:58Arno Nierich: How Caffeine Affects Red Blood Cells and Blood Storage
-
Oct 21, 2025, 06:43Could Gene Therapy Offer Lasting Quality of Life for People with Hemophilia B?
-
Oct 24, 2025, 11:28Louise Bannon and Thomas Reiser Thank World Thrombosis Day Supporters Around The World
-
Oct 24, 2025, 10:48Melanie Daniel Congratulates Mickael Rosa and Antoine Rauch on Winning Bernd R. Binder Prize
-
Oct 24, 2025, 10:47Nan van Geloven Was Awarded The Prestigious Vidi Grant
-
Oct 23, 2025, 06:52Louise Bannon: Thrilled to Witness The Incredible Reach of This Year's World Thrombosis Day!
-
Oct 23, 2025, 06:50Caitlin Raymond to Speak at The 11th Annual Bloodless Medicine and Surgery Society Conference